Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema

European Respiratory Journal

Volumn 9, Issue 8, 1996, Pages 1656-1659

  Bouros, D ^a,b   Schiza, S ^a   Tzanakis, N ^b   Drositis, J ^a   Siafakas, N ^a,b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Empyema; Fibrinolytics; Pleural effusion complications; Pleural empyema; Respiratory infections; Urokinase

Indexed keywords

UROKINASE;

ARTICLE; CLINICAL ARTICLE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; EMPYEMA; HUMAN; INTRAPLEURAL DRUG ADMINISTRATION; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029741271     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09081656     Document Type: Article

References (20)

1. Light RW. Pleural disease. Dis Mon 1992; 38: 261-331.
2. Light RW. Parapneumonic effusions and empyema. Clin Chest Med 1985; 6: 55-62.
3. Bartlett JG. Bacterial infections of the pleural space. Semin Respir Infect 1988; 3: 308-321.
4. Orringer MB. Thoracic empyema: back to basics. Chest 1988; 93: 901-902.
5. Bartlett JG, Finegold SM. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis 1974; 110: 56-77.
6. Kaplan DK. Treatment of empyema thoracis. Thorax 1994; 49: 845-846.
7. Bouros D, Schiza S, Panagou P, et al. Role of streptokinase in the treatment of acute loculated parapneumonic pleural effusions and empyema. Thorax 1994; 49: 852-855.
8. Tillet WS, Sherry S. The effect in patients of streptococcal fibrinolysis (streptokinase) and streptococcal des- oxyribonuclease on fibrinous purulent and sanguinous pleural exudations. J Clin Invest 1949; 28: 173-190.
9. Bergh NP, Ekroth R, Larsson S, Nagy P. Intrapleural streptokinase in the treatment of hemothorax and empyema. Scand J Thorac Cardiovasc Surg 1977; 11: 265-268.
10. Henke CA, Leatherman JW. Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions. Am Rev Respir Dis 1992; 145: 680-684.
11. Taylor RFH; Rubens MB, Pearson MC, Barnes NC. Intrapleural streptokinase in the management of empyema. Thorax 1994; 49: 856-859.
12. Sahn SA. Managment of complicated parapneumonic effusions. Am Rev Respir Dis 1993; 148: 813-817.
13. Spann JF, Sherry S, Rubin RN. Techniques of achieving pulmonary, peripheral and coronary thrombolysis. In: Hurst JW, Schlant RC, Rackley CE, Sonnenblick EH, Wenger NK, eds. The Heart. New York, McGraw Hill, 1990; pp. 2177-2184.
14. Moulton JS, Moore PT, Mencini RA. Treatment of loculated pleural effusions with transcatheter intracavitary urokinase. AJR 1989; 153: 941-945.
15. Lee KS, Im JG, Kim YH, et al. Treatment of thoracic multiloculated empyemas with intracavitary urokinase: a prospective study. Radiology 1991; 179: 771-775.
16. Couser JI, Berley J, Timm EG. Intrapleural urokinase for loculated effusions. Chest 1992; 101: 1467-1469.
17. Robinson LA, Moulton A, Flemming WH. Intrapleural fibrinolytic treatment of multiloculated thoracic empyemas. Ann Thorac Surg 1994; 57: 803-814.
18. Pollack JS, Passik CS. Intrapleural urokinase in the treatment of loculated pleural effusions. Chest 1994; 105: 868-873.
19. Lahora JM, Haaga JR, Stellate T, et al. Safety of intracavitary urokinase with percutaneous abscess drainage. AJR 1993; 160: 171-174.
20. Schiza S, Bouros D, Panagou P, et al. Intrapleural streptokinase vs urokinase in the treatment of loculated parapneumonic effusions. Eur Respir J 1994; 7: 272s.